Answers are grounded in this paper and cite their sources.
The current study demonstrates a novel, eco-friendly synthesis of silver nanoparticles (AgNPs) using Mitragyna parvifolia leaf extract, guided by a Quality by Design (QbD) approach to enhance their anti-inflammatory efficacy. Distinct from conventional chemical methods, this green strategy leverages phytochemicals as natural reducing and stabilizing agents. A central composite design was employed to optimize reaction temperature and incubation time, enabling controlled nanoparticle synthesis with improved bio-efficacy. The synthesized AgNPs were characterized using spectroscopic and microscopic techniques, confirming the formation of spherical, crystalline nanoparticles with a zeta potential of –27.1 mV, indicative of high stability. UV–Vis spectroscopy revealed a surface plasmon resonance peak at 438 nm, while FTIR analysis indicated the presence of functional groups (–NH, –CH, – C = C ), confirming successful capping by M. parvifolia phytoconstituents. XRD analysis confirmed a face-centered cubic structure with an average crystallite size of 13.05 nm, and TEM analysis revealed well-dispersed spherical particles ranging from 18 to 22 nm, with SAED patterns supporting their crystalline nature. The anti-inflammatory potential of the synthesized AgNPs was evaluated in vitro, showing significant COX-2 inhibition (IC 50 = 56.49 µg/ml), protein denaturation inhibition (73.89 % at 300 µg/ml), and membrane stabilization (85.94 % at 100 µg/ml), substantially outperforming the crude extract. These enhancements are attributed to the nanoscale size and effective phytochemical interaction. This study underscores the promise of QbD-optimized, plant-mediated AgNPs as potential anti-inflammatory agents and highlights their relevance in the development of sustainable nanomedicine.
No takes yet. Share an insight, caveat, or question.
Pote et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: